CIK 0001816590 · Non-accelerated filer<br>Smaller reporting company
COMPASS Pathways plc
Sign in to watch- Ticker
- CMPS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 1-716-676-6461
- Business address
- 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESIRE, United Kingdom, WA14 2DT
- Former names
- Compass Rx Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-01 | Nath Kabir Chief Executive Officer | Grant or award · Share Option (Right to Buy) | +275,000 | 275,000 | ||
| 2024-02-01 | Goodwin Guy Chief Medical Officer | Grant or award · Share Option (Right to Buy) | +63,000 | 63,000 | ||
| 2024-02-01 | Goodwin Guy Chief Medical Officer | Grant or award · Share Option (Right to Buy) | +32,000 | 32,000 | ||
| 2024-02-01 | Hughes Mary-Rose Interim CFO | Grant or award · Share Option (Right to Buy) | +18,700 | 18,700 | ||
| 2024-02-01 | Hughes Mary-Rose Interim CFO | Grant or award · Share Option (Right to Buy) | +6,200 | 6,200 | ||
| 2024-02-01 | Jenkins Annalisa Director | Shares withheld for taxes | −175 | $11.34 | $2K | 19,852 |
| 2024-02-01 | Goldsmith George Jay Director | Shares withheld for taxes | −5,283 | $11.34 | $60K | 4,167,121 |
| 2024-02-01 | Goldsmith George Jay Director | Shares withheld for taxes | −3,301 | $11.34 | $37K | 4,166,444 |
| 2024-02-01 | Malievskaia Ekaterina Director | Shares withheld for taxes | −3,301 | $11.34 | $37K | 4,166,444 |
| 2024-02-01 | Malievskaia Ekaterina Director | Shares withheld for taxes | −5,283 | $11.34 | $60K | 4,167,121 |
| 2024-01-22 | Goldsmith George Jay Director | Sale 10b5-1 | −25,750 | $8.35 | $215K | 4,172,404 |
| 2024-01-22 | Goldsmith George Jay Director | Sale 10b5-1 | −25,750 | $8.35 | $215K | 4,169,745 |
| 2024-01-22 | Malievskaia Ekaterina Director | Sale 10b5-1 | −25,750 | $8.35 | $215K | 4,169,745 |
| 2024-01-22 | Malievskaia Ekaterina Director | Sale 10b5-1 | −25,750 | $8.35 | $215K | 4,172,404 |
| 2024-01-19 | Goldsmith George Jay Director | Sale 10b5-1 | −20,205 | $7.99 | $161K | 4,198,154 |
| 2024-01-19 | Goldsmith George Jay Director | Sale 10b5-1 | −20,206 | $7.99 | $161K | 4,195,495 |
| 2024-01-19 | Malievskaia Ekaterina Director | Sale 10b5-1 | −20,206 | $7.99 | $161K | 4,195,495 |
| 2024-01-19 | Malievskaia Ekaterina Director | Sale 10b5-1 | −20,205 | $7.99 | $161K | 4,198,154 |
| 2024-01-03 | Goldsmith George Jay Director | Sale 10b5-1 | −21,758 | $8.74 | $190K | 4,218,359 |
| 2024-01-03 | Goldsmith George Jay Director | Sale 10b5-1 | −21,758 | $8.74 | $190K | 4,215,701 |
Page 7 of 12 · 230 trades